Medical Marijuana: Consumers’ Perspectives in the US and UK

2020-04-30
Price :
Published : Apr-2020
No. of Pages : 55

Medical Marijuana: Consumers’ Perspectives in the US and UK

Summary

GlobalData’s Medical Marijuana, Consumers’ Perspectives report combines an extensive survey and analysis of patients’ perspectives in the US and UK to provide an in-depth consumer-centered review of the medical marijuana market. Components of the report include an in-depth breakdown of the survey and its respondents, detailed analysis of consumers’ concerns and opinions of medical and recreational marijuana, information from interviews with patients receiving treatment with medical marijuana in the US and UK, and an assessment of the impact of the COVID-19 pandemic on the medical marijuana space.

The report evaluates trends across different age groups, health statuses, and other parameters to inform insightful comparisons and market-specific analyses, always linking the significance of the findings to the historical and contemporary events underpinning consumers’ perspectives in the two countries on which this thematic research focuses on.

Key Highlights

– The majority (72%) of respondents stated that one of their greatest concerns with regards to receiving treatment with medical marijuana therapies was the potential for psychological side effects and cognitive impairment.
– More respondents from the UK (34%) than respondents from the US (25%) were in favor of legalizing recreational marijuana. Differently, 91% of respondents from the US and 87% of respondents from the UK were in favor of legalizing marijuana for medicinal purposes.
– Many respondents from both markets expressed feelings of uncertainty about the law regarding the use of medical marijuana. This was mainly due to the dynamic regulatory landscape in which restrictions are repeatedly altered with little attention drawn to these modifications.
– Although the use of medical marijuana is well documented for some indications such as pain, muscle spasticity, and epilepsy, many sufferers of other conditions remain unsure about its efficacy for other diseases, despite the active clinical trials landscape.
– Increased media coverage and attention on medical marijuana is attracting a wide audience.
– The reputation of marijuana is changing alongside the emergence of results from clinical studies that aim to prove that the applications in medicine may be more widespread than what was previously believed.
– According to GlobalData’s primary research, the COVID-19 pandemic and lockdown measures are already changing operations within the medical marijuana industry.
– The ability to access medical marijuana differs across state borders in the US, and constituencies in the UK, and these discrepancies are expected to increase further against the backdrop of the COVID-19 pandemic.

Scope

– The report provides an overview of the design of the study, including a breakdown of the respondents from each of the markets.
– Other components include the analysis of key perspectives, broken down into different age groups and presence or absence of chronic illness, a discussion of the unmet needs, legal restrictions on medical marijuana, evaluation of the scientific evidence to support the use of medical marijuana, and an assessment of the potential impact of COVID-19 on the medical marijuana space.
– In the report, there is also analysis of key concerns of consumers in the US and UK and a discussion of the findings from interviews with consumers who personally benefit from receiving treatment with medical marijuana.
– In addition, there is an examination of the stigmatization of marijuana users and an overview of social issues regarding the perception of recreational marijuana.

Reasons to Buy

– Develop and design your in-licensing and out-licensing strategies with consumers’ perspectives in mind in order to gain an insight into the methods to develop products with the greatest chance of success in the medical marijuana environment.
– Identify potential agreements, partnerships, licensing or M&A opportunities in line with the strategies most likely to provide appropriate solutions for issues raised by underserved patients in the medical marijuana space.
– Examine consumers’ perspectives on various aspects of treatment with respect to medical marijuana therapies.
– Develop business strategies by understanding the trends shaping and driving the medical marijuana space from consumers’ perspectives.
– Drive revenues by understanding the key trends in consumer sentiments and what actions need to be taken to companies who wish to gain a foothold in the medical marijuana environment.
– Formulate effective sales and marketing strategies by understanding the medical marijuana landscape and identify the unmet needs for patients in this therapy area.
– Examine the impact of COVID-19 on the medical marijuana space and devise strategies to minimize the effects of the pandemic on businesses and patients alike.
– Organize your sales and marketing efforts by identifying the consumers that are most likely to have a vested interest in medical marijuana, allowing your company to capitalize on opportunities for consolidations, investments and strategic partnerships.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Teleradiology Market by Products & Services (Services, Hardware, Software (PACS, RIS)), Imaging Technique (MRI, CT, X-ray, Ultrasound, Mammography, Nuclear Imaging), End User (Hospitals, Diagnostic Centers & Laboratories), COVID-1 Impact – Forecast to 2025

“Dearth of skilled radiologists & need for faster and improved diagnosis are driving market growth” The teleradiology market is expected to reach USD 22.8 billion by 2025 from USD 7.9 billion in 2020, at a CAGR of 23.5% during the forecast period of 2020 to 2025. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for teleradiology services. The growth of this market is mainly attributed to the rising geriatric population and the subsequent increase in the prevalence of associated diseases, the increasing adoption of cloud-based solutions, and the benefits offered by teleradiology and a dearth of skilled radiologists. However, declining reimbursements and increasing regulatory burden in the US and data breaching of imaging report hampered market gr......
$5650

Coronavirus Disease 2019 – Epidemiology Analysis and Forecast – June 2020

Coronavirus Disease 2019 - Epidemiology Analysis and Forecast - June 2020 Summary The pandemic's epicenters have shifted to Latin America, India, Pakistan, and South Africa. COVID-19 is mainly affecting the dense populous and poorer regions of these countries. As a result, the global daily confirmed cases are increasing at a higher pace than before. The US continues to be the most affected country globally, reaching close to 2.5 million cases. The US reported the highest number of new daily cases on 26 June since the start of the pandemic. Chile moves up ahead of Spain. Brazil has now reported more than 1 million total confirmed cases of COVID-19. Mexico is now ranked 11th among the top most affected countries. The report covers current epidemiology situation, forecast, and analysis ......
$1995

Amyloidosis – Epidemiology Forecast to 2029

Amyloidosis - Epidemiology Forecast to 2029 Summary Amyloidosis is a rare disease characterized by extracellular and/or intracellular deposition of insoluble abnormal amyloid fibrils that alters the normal functions of the tissues in the organs (Holmes et al., 2019; Mayo Clinic, 2020). Amyloid is not normally found in the body, but it can be formed from several different types of protein and interferes with the organs' normal function. Organs that may be affected by amyloidosis include the heart, kidneys, liver, spleen, nervous system, and digestive tract (Mayo Clinic, 2020). The signs and symptoms of amyloidosis include dizziness, fluid retention, fatigue, fainting, an enlarged tongue, low blood pressure, and shortness of breath (Mayo Clinic, 2020; Stanford Health Care, 2020). There ar......
$3995

Transthyretin Amyloidosis – Global Drug Forecast and Market Analysis to 2029

Transthyretin Amyloidosis - Global Drug Forecast and Market Analysis to 2029 Summary Amyloidosis is a protein confirmation disorder that results in the build-up of insoluble amyloid proteins in tissues. This build-up can be fatal as it leads to disruption of organ systems and causes oxidative stress within the body. There are various forms of amyloidosis, each associated with the protein involved and the underlying cause of protein mis-folding. Amyloid aggregates affect different organs, most commonly the heart, kidney and liver whilst also affecting the peripheral, autonomic and gastro-intestinal (GI) systems. Most amyloidosis diagnoses are made later in life, with the average patient aged 65 at diagnosis. Transthyretin Amyloidosis (ATTR) is caused by the transthyretin (TTR) protein an......
$10995

Impact on Publicly Traded Bio/Pharma Companies – Coronavirus Disease (COVID-19) 2019 Impact Report

Impact on Publicly Traded Bio/Pharma Companies - Coronavirus Disease (COVID-19) 2019 Impact Report Summary The Coronavirus (COVID-19) company impact report analyses how the pandemic has impact the top 20 Mega Cap Bio/Pharma Companies revenue, future revenue, and market capitalization. Scope - This report gives an important expert analysis on how COVID-19 has affected, and will continue to affect, the top 20 Mega Cap Bio/Pharma Companies. Findings are based on the industry's most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis. Reasons to Buy - An overview of how the top 20 Mega Cap Bio/Pharma Companies have been affected, and will continue to be affected, by the COVID-19 pandemic.......
$695

Acute Myeloid Leukemia (AML) – Opportunity Analysis and Forecasts to 2029

Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2029 Summary Acute myeloid (or myelogenous or myelocytic) leukemia (AML) is a malignancy of the hematopoietic system caused by abnormal proliferation or differentiation of myeloid progenitors in the bone marrow and peripheral blood. AML is relatively rare and has a poor prognosis, particularly in elderly patients. Until recently, chemotherapy and hypomethylating agents were the only treatment options, but since 2017 this has changed with the introduction of premium-priced novel therapies. The global AML market is expected to grow from $1.4B in 2019 to $5.1B in 2029 at a compound annual growth rate (CAGR) of 13.6%. This dramatic growth is driven by the launch of 16 new pipeline agents in the 7MM and 12 in China, by the......
$10995

Acute Myeloid Leukemia – Epidemiology Forecast to 2029

Acute Myeloid Leukemia - Epidemiology Forecast to 2029 Summary Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow in which the bone marrow produces abnormal red blood cells, white blood cells, or platelets, and generally progresses at a rapid pace. AML is more common in the elderly, is associated with severe complications and high mortality, and accounts for a disproportionately high number of cancer-related deaths. AML is often called acute myelogenous leukemia, acute myeloblastic leukemia, acute granulocytic leukemia, and acute nonlymphocytic leukemia. In 2019, there were 72,164 diagnosed incident cases of AML in the 8MM in men and women combined for ages 18 years and older. GlobalData epidemiologists estimate that globally, cases will rise to 90,264 at an Annual Gr......
$3995

Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) – Global Forecast to 2025

 “The aseptic sampling market is projected to grow at a CAGR of 12.4% during the forecast period (2020–2025).” The global aseptic sampling market size is projected to reach USD 474 million by 2025 from USD 264 million in 2020, at a CAGR of 12.4%. The growth of this market is driven majorly by factors such as the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities. On the other hand, issues related to leachables and extractable from single-use products are restraining market growth. “By type, the manual aseptic sampling segment is expected to grow at the highest CAGR during the forecast period.” Based on type, the aseptic sampling market is segmented into manual aseptic......
$4950

Impact of COVID-19 on Pharmaceutical Social Media Influencer Activity

Impact of COVID-19 on Pharmaceutical Social Media Influencer Activity Summary The highly contagious coronavirus (SARS-CoV-2), dubbed COVID-19 (formerly 2019-nCoV), which emerged at the close of 2019, has led to a medical emergency across the world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020. This report analyzes GlobalData's social media Influencer dashboards to understand Influencer trends since the pandemic began and what key Influencers are discussing online about COVID-19. This report analyzes Influencer trends since the pandemic began and what assesses what key Influencers are discussing online about the virus. Scope The report includes 10 Influencers - - Eight therapy areas: Cardiovascular, Metabolic Disord......
$995

Digital Biomarkers – Coronavirus Disease 2019 (COVID-19) Case Study

Digital Biomarkers - Coronavirus Disease 2019 (COVID-19) Case Study Summary The ongoing COVID-19 crisis has seen social distancing and lockdown measures implemented around the world, which has had widespread effects on the healthcare industry, particularly in the ways that patients and healthcare professionals can safely interact while minimizing risks of viral transmission. Remote patient monitoring and the collection of digital biomarkers by connected devices has emerged as an important approach to support patients and healthcare systems during the pandemic. This case study assesses how connected devices and digital biomarkers can be used during the COVID-19 pandemic and beyond. Key Highlights - Digital biomarkers are an important addition to the armamentarium of tools supporting pa......
$595
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy